Engineering a region of bulk tolerance in the 5-ht(2a) receptor

European Journal of Medicinal Chemistry

Volumn 34, Issue 5, 1999, Pages 441-447

  Westkaemper, Richard B ^a   Hyde, Edward G ^b   Choudhary, Mohammad S ^b   Khan, Naseem ^b   Gelbar, Edward I ^b   Glennon, Richard A ^a   Roth, Bryan L ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antagonist; Ketanserin; Modelling; Mutagenesis; Serotonin receptor

Indexed keywords

BENZILIC ACID; KETANSERIN; LEUCINE; PHENYLALANINE; SEROTONIN 2A RECEPTOR;

ARTICLE; BINDING AFFINITY; CHEMICAL MUTAGENESIS; DRUG RECEPTOR BINDING; DRUG STRUCTURE;

EID: 0032705446     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(99)80094-4     Document Type: Article

References (33)

1. Roth B.L. Ann. Clin. Psych. 6:1994;67-78.
2. Glennon R.A., Dukat M. Bloom F.E, Kuptfer D.J. Serotonin receptor subtypes, Psychopharmacology: The Fourth Generation of Progress. 1995;415-429 Raven Press, NY.
3. Choudhary M.S., Craigo S., Roth B.L. Mol. Pharmacol. 43:1993;755-763.
4. Choudhary M.S., Sachs N., Uluer A., Glennon R.A., Westkaemper R.B., Roth B.L. Mol. Pharmacol. 47:1995;627-633.
5. Roth B.L., Shoham M., Choudhary M.S., Khan N. Mol. Pharmacol. 52:1997;259-266.
6. Almaula N., Ebersole B.J., Zhang D., Weinstein H., Sealfon S.C. J. Biol. Chem. 271:1996;14672-14675.
7. Wang C.D., Gallaher T.K., Shih J.C. Mol. Pharmacol. 43:1993;931-940.
8. Johnson M.P., Loncharich R.J., Baez M., Nelson D.L. Mol. Pharmacol. 45:1994;277-286.
9. Hibert M.F., Trumpp-Kallmeyer S., Bruinvels A., Hoflack J. Mol. Pharmacol. 40:1991;8-15.
10. Kristiansen K., Edvardsen O., Dahl S.G. Med. Chem. Res. 3:1993;370-385.
11. Kristiansen A., Dahl S.G. Eur J. Pharm. 306:1996;195-210.
12. Westkaemper R.B., Glennon R.A. Med. Chem. Res. 3:1993;317-334.
13. Glennon R.A., Dukat M., Westkaemper R.B., Ismaiel A.M., Izzarelli D.G., Parker E.M. Mol. Pharmacol. 49:1996;198-206.
14. Glennon R.A., Westkaemper R.B. Angeli P, Gulini U, Quaglia W. Trends in Receptor Research. 1992;185-207 Elsevier, Amsterdam.
15. Ismaiel A.M., Arruda K., Teitler M., Glennon R.A. J. Med. Chem. 38:1995;1196-1262.
16. Herndon J.L., Ismaiel A., Ingher S.P., Teitler M., Glennon R.A. J. Med. Chem. 35:1992;4903-4910.
17. Glennon R.A., Dukat M. ID Res. Alerts. 1997;2107-2113.
18. Weiland K., Zuurmond H.M., Krasel C., Ijzerman A.P., Loshe M.J. Proc. Natl. Acad. Sci. USA. 93:1996;9276-9281.
19. Roth B.L., Willins D.L., Kristiansen K., Kroeze W.K. Pharmacol. Ther. 79:1998;231-257.
20. Strader C.D., Sigal I.S., Dixon R.A.F. FASEB J. 3:1989;1825-1831.
21. Cho W., Taylor L.P., Mansour A., Akil H. J. Neurochem. 65:1995;2105-2115.
22. Surratt C.K., Johnson P.S., Moriwaki A., Seidleck B.K., Blaschank C.J., Wang J.B., Uhl G.R. J. Biol. Chem. 269:1994;20548-20553.
23. Gether U., Emonds-Alt X., Breliere J.C., Fujii T., Hagiwara D., Pradier L., Garret C., Johansen T.E., Schwartz T.W. Mol. Pharmacol. 45:1994;500-508.
24. Wess J., Nanavati S., Vogel Z., Maggio R. EMBO J. 12:1993;331-338.
25. Cullen B.R. Guide to Molecular Cloning Techniques. 1987;684-705 Academic Press, New York.
26. Roth B.L., Choudhary M.S., Khan N., Uluer A.Z. J. Pharmacol. Exp. Ther. 280:1997;576-583.
27. Roth B.L., Nakaki T., Chuang D.M., Costa E. J. Pharmacol. Exp. Ther. 238:1986;480-485.
28. Munson P.J., Rodbard D. Anal. Biochem. 107:1980;220-239.
29. Baldwin J.M. EMBO J. 12:1993;1693-1703.
30. Schertler G.F., Villa C., Henderson R. Nature. 362:1993;770-772.
31. Unger V.M., Schertler G.F. Biophys. J. 68:1995;1776-1786.
32. Schertler G.F., Hargrave P.A. Proc. Natl. Acad. Sci. USA. 92:1995;11578-11582.
33. McGregor M.J., Islam S.A., Sternberg M.J.E. J. Mol. Biol. 198:1987;295-310.